In Collaboration with:
All countries across the world are facing the same challenge: how to ensure the continued availability of medicines for the patients during the COVID-19 pandemic while maintaining high standards of medication safety.
We have invited MENA region pharmacovigilance experts to speak about the
- Latest updates in PV measures and new requirements
- Quality challenges for safety reporting activities due to the COVID-19 pandemic
- Importance of electronic reporting to ensure data exchange for patient safety
